202 related articles for article (PubMed ID: 17559347)
1. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.
Li Q; Chen BL; Ozdemir V; Ji W; Mao YM; Wang LC; Lei HP; Fan L; Zhang W; Liu J; Zhou HH
Pharmacogenomics; 2007 Jun; 8(6):577-86. PubMed ID: 17559347
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
Lev EI; Patel RT; Guthikonda S; Lopez D; Bray PF; Kleiman NS
Thromb Res; 2007; 119(3):355-60. PubMed ID: 16581111
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C
Thromb Res; 2011 Jul; 128(1):47-53. PubMed ID: 21429568
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
[TBL] [Abstract][Full Text] [Related]
6. A study into the genetic basis of aspirin resistance in Pakistani patients with coronary artery disease.
Mukarram O; Akhtar N; Junaid A; Mohyuddin A
Pak J Pharm Sci; 2016 Jul; 29(4):1177-82. PubMed ID: 27393450
[TBL] [Abstract][Full Text] [Related]
7. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
Gao F; Wang ZX; Men JL; Ren J; Wei MX
Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
[TBL] [Abstract][Full Text] [Related]
8. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.
Bierend A; Rau T; Maas R; Schwedhelm E; Böger RH
Br J Clin Pharmacol; 2008 Apr; 65(4):540-7. PubMed ID: 17995973
[TBL] [Abstract][Full Text] [Related]
9. Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients.
Yi X; Wang C; Zhou Q; Lin J
BMC Neurol; 2017 Jan; 17(1):4. PubMed ID: 28068952
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?
Papp E; Havasi V; Bene J; Komlosi K; Czopf L; Magyar E; Feher C; Feher G; Horvath B; Marton Z; Alexy T; Habon T; Szabo L; Toth K; Melegh B
Ann Pharmacother; 2005 Jun; 39(6):1013-8. PubMed ID: 15840736
[TBL] [Abstract][Full Text] [Related]
11. The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin.
Abderrazek F; Chakroun T; Addad F; Dridi Z; Gerotziafas G; Gamra H; Hassine M; Elalamy I
Thromb Res; 2010 Jun; 125(6):e265-8. PubMed ID: 20138334
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
[TBL] [Abstract][Full Text] [Related]
13. Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C.
Yi X; Zhou Q; Lin J; Chi L; Han Z
J Atheroscler Thromb; 2013; 20(1):65-72. PubMed ID: 22972377
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of aspirin resistance: a comprehensive systematic review.
Goodman T; Ferro A; Sharma P
Br J Clin Pharmacol; 2008 Aug; 66(2):222-32. PubMed ID: 18429969
[TBL] [Abstract][Full Text] [Related]
15. Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.
Kim KA; Song WG; Lee HM; Joo HJ; Park JY
Thromb Res; 2013 Aug; 132(2):221-6. PubMed ID: 23849096
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of the platelet glycoprotein IIIa Pl(A1/A2) polymorphism in three South African ethnic groups and its effect on platelet function.
Naran NH; Chetty N; Crowther NJ
Thromb Res; 2008; 123(2):316-23. PubMed ID: 18657307
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
[TBL] [Abstract][Full Text] [Related]
18. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
[TBL] [Abstract][Full Text] [Related]
19. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP.
Hetherington SL; Singh RK; Lodwick D; Thompson JR; Goodall AH; Samani NJ
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):252-7. PubMed ID: 15514209
[TBL] [Abstract][Full Text] [Related]
20. Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke.
Yi X; Zhou Q; Wang C; Lin J; Liu P; Fu C
Eur J Clin Pharmacol; 2017 Apr; 73(4):437-443. PubMed ID: 28091702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
